β-adrenoceptor subtype activities of trimetoquinol derivatives: Biochemical studies on human β-adrenoceptors expressed in Chinese hamster ovary cells

Journal of Pharmacology and Experimental Therapeutics

Volumn 291, Issue 2, 1999, Pages 875-883

  Konkar, Anish A ^a   Vansal, Sandeep S ^d   Shams, Gamal ^a   Fraundorfer, Paul F ^a   Zheng, Wei Ping ^c   Nikulin, Victor I ^c   De Los Angeles, Joseph ^c   Fertel, Richard H ^b   Miller, Duane D ^c   Feller, Dennis R ^a,d,e  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^d UNIVERSITY OF MISSISSIPPI   (United States)

^e UNIVERSITY OF MISSISSIPPI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3',4',5' TRIIODOTRIMETOQUINOL; 3',4',5' TRIMETHOXYBENZYLTETRAHYDROTHIAZOLOPYRIDINE; 3',5' DIIODO 4' DESMETHOXYTRIMETOQUINOL; 3',5' DIIODOTRIMETOQUINOL; 3,5, DIIODO 4' METHOXYBENZYLTETRAHYDROTHIAZOLOPYRIDINE; 4 (3 TERT BUTYLAMINO 2 HYDROXYPROPOXY) 2 BENZIMIDAZOLONE; 4 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL]PHENOXYACETIC ACID; 5,8 DIFLUOROTRIMETOQUINOL; 7 CHLOROTRIMETOQUINOL; 8 FLUOROTRETOQUINOL; BETA ADRENERGIC RECEPTOR; ISOPRENALINE; TRETOQUINOL; TRETOQUINOL DERIVATIVE; UNCLASSIFIED DRUG;

ADRENERGIC ACTIVITY; ANIMAL CELL; ARTICLE; DRUG ACTIVITY; DRUG POTENCY; DRUG RECEPTOR BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADRENERGIC BETA-AGONISTS; ANIMALS; CATECHOLS; CHO CELLS; CRICETINAE; CYCLIC AMP; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; ISOPROTERENOL; RADIOLIGAND ASSAY; RECEPTORS, ADRENERGIC, BETA; TRETOQUINOL;

EID: 0032740144     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Arch JRS, Ainsworth AT, Cawthorne MA, Piercy V, Sennitt MV, Thody VE, Wilson C and Wilson S (1984) Atypical β-adrenoceptor on brown adipocytes as target for antiobesity drugs. Nature (Lond) 309:163-165.
2. 3 and atypical β-adrenoceptors. Med Res Rev 13:663-729.
3. 3-adrenoceptor agonists in the treatment of obesity and diabetes. Int J Obes 20:191-199.
4. 3-adrenergic receptor. Mol Pharmacol 44:1094-1104.
5. Brooker G, Harper JF, Terasaki WL and Moylan RD (1979) Radioimmunoassay of cyclic AMP and GMP, in Advances in Cyclic Nucleotide Research (Brooker G, Greengard P and Robinson A eds) pp 1-33, Raven Press, New York.
6. 50) of an enzymatic reaction. Biochem Pharmacol 22:3099-3108.
7. 2-adrenoceptor agonists. J Med Chem 30:86-90.
8. 3-adrenergic receptor. Eur J Endocrin 136:362-365.
9. 3-adrenergic receptor. Science (Wash DC) 245:1118-1121.
10. Fedyna JS, Adejare A, Miller DD and Feller DR (1987) Pharmacological evaluation of the β-adrenoceptor agonist and thromboxane antagonist properties of N-substituted trimetoquinol analogs. Eur J Pharmacol 135:161-171.
11. Feller DR, Piascik MT and Miller DD (1978) Activation of adrenoceptors and adenylate cyclase in adipocytes by catecholamines and tetrahydroisoquinolines, in Recent Advances in the Pharmacology of Adrenoceptors (Szabadi E, Bradshaw CM and Bevan P eds) pp 111-120, Elsevier, New York.
12. Fraundorfer PF (1993) Functional and biochemical characterization of trimetoquinol analog interactions with β-adrenergic receptor subtypes. Ph.D. dissertation, The Ohio State University, Columbus, Ohio.
13. Fraundorfer PF, Lezama EJ, Salazar-Bookaman MM, Fertel RH, Miller DD and Feller DR (1994) Isomeric-activity ratios of trimetoquinol enantiomers on β-adrenergic receptor subtypes: Functional and biochemical studies. Chirality 6:76-85.
14. Furchgott RF and Bursztyn P (1967) Comparison of dissociation constants and relative efficacies of selected agonists on parasympathetic receptors. Ann N Y Acad Sci 144:882-889.
15. 3-adrenergic receptor. Mol Pharmacol 40:895-899.
16. 3-adrenergic receptors: Involvement of the seventh transmembrane region in conferring subtype specificity. Mol Pharmacol 53:856-861.
17. Hollenga C and Zaagsma J (1989) Direct evidence for the atypical nature of functional β-adrenoceptors in rat adipocytes Br J Pharmacol 98:1420-1424.
18. Jockers R, Issad T, Zilberfarb V, de Coppet P, Marullo S and Strosberg AD (1998) Desensitization of the β-adrenergic response in human brown adipocytes. Endocrinology 139:2676-2684.
19. Kenakin TP (1985) The quantification of relative efficacy of agonists. Trends Pharmacol Sci 13:281-308.
20. Kenakin T (1997) Differences between natural and recombinant G protein-coupled receptor systems with varying receptor/G protein stoichiometry. Trends Pharmacol Sci 18:456-464.
21. Kirk KL and Creveling CR (1984) The chemistry and biology of ring-fluorinated biogenic amines. Med Res Rev 4:189-220.
22. Konkar AA, Fraundorfer PF, Fertel RH, Burkman AM, Miller DD and Feller DR (1996) Pharmacological activities of trimetoquinol and 1-benzyl halogen-substituted analogues on rat β-adrenoceptor subtypes. Eur J Pharmacol 305:63-71.
23. Lands AM, Arnold A, McAuliff JP, Luduena FP and Brown TG (1967) Differentiation of receptor systems activated by sympathomimetic amines. Nature (Lond) 214: 597-598.
24. Lowry OH, Rosebrough NJ, Farr AL and Randall RJ (1951) Protein measurement with Folin phenol reagent. J Biol Chem 193:265-275.
25. Lezama EJ, Konkar AA, Salazar-Bookaman MM, Miller DD and Feller DR (1996) Pharmacological study of atypical β-adrenoceptors in rat esophageal smooth muscle. Eur J Pharmacol 308:69-80.
26. 3-adrenergic receptors: Differential agonist activation of recombinant receptors in Chinese hamster ovary cells. Mol Pharmacol 42:634-637.
27. 2) antagonist activities. J Med Chem 35:466-479.
28. Picó C, Bonet ML and Palou A (1998) Stimulation of uncoupling protein synthesis in white adipose tissue of mice treated with the β3-adrenergic agonist CGP-12177. Cell Mol Life Sci 54:191-195.
29. Schneider CS and Mierau CS (1987) Dopamine autoreceptor: Resolution and pharmacological activity of 2,6-diaminotetrahydrobenzothiazole and an aminothiazole analogue of apomorphine. J Med Chem 30:494-498.
30. 3-adrenoceptor agonists of differing selectivities. J Pharmacol Exp Ther 285: 1084-1095.
31. Shams G, Romstedt KJ, Gerhardt MA, Harrold MW, Miller DD and Feller DR (1990) Pharmacological evaluation of the β-adrenoceptor agonist and thromboxane receptor blocking properties of 1-benzyl substituted trimetoquinol analogues. Eur J Pharmacol 184:21-31.
32. 3-adrenergic receptor. Annu Rev Pharmacol Toxicol 37:421-450.
33. 3-adrenoceptor polymorphism with obesity and diabetes: Current status. Trends Pharmacol Sci 18:449-454.
34. 3-adrenoceptor. Trends Pharmacol Sci 17:373-381.
35. Tate KM, Briend-Sutren M-M, Emorine LJ, Delavier-Klutchko C, Marullo S and Strosberg AD (1991) Expression of three human β-adrenergic-receptor subtypes in transfected Chinese hamster ovary cells. Eur J Biochem 196:357-361.
36. 3-Adrenergic agonist induces a functionally active uncoupling protein in fat and slow-twitch muscle fibers. Am J Physiol 274:E469-E475.